News Related to Seagen

Related coverage linked through entity extraction aliases.

HER2-Positive Gastric Cancer Pipeline Expands with 20+ Therapies in Development

Mar 22, 2026

Over 20 pharmaceutical companies are developing therapies for HER2-positive gastric cancer, with multiple Phase III trials launched in March 2026 testing novel combination treatments for advanced disease.

Pfizer Advances Oncology Pipeline with BRAFTOVI Trial Success and HYMPAVZI Expansion

Mar 06, 2026

Pfizer reported positive Phase 3 trial results for BRAFTOVI combination therapy in metastatic colorectal cancer and received FDA Priority Review for HYMPAVZI expansion to hemophilia patients including children.